# Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity

> **NCT04729153** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** DAAD Compound

## Key facts

- **NCT ID:** NCT04729153
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02
- **Primary completion:** 2022-02
- **Final completion:** 2022-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04729153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04729153, "Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04729153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*